7 pending office actions • 4 art units • 6 examiners • 0 of 7 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (14%) |
| §103 only | 2 (29%) |
| Double-patenting + other | 3 (43%) |
| Multi-statute (no §101) | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZHU, JIANJIAN | 2 | 61.0% | +83.7% |
| SANG, HONG | 1 | 54.7% | +62.6% |
| ALDARONDO, DASIA ALI | 1 | 0.0% | +0.0% |
| WENG, KAI H | 1 | 70.2% | +17.3% |
| MIANO, JOSEPH PAUL | 1 | 36.1% | +64.0% |
| HALVORSON, MARK | 1 | 48.1% | +21.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16695894 | CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND METHODS OF USE THEREOF | HALVORSON, MARK | 71d overdue |
| 18361056 | ENGINEERED CELLS WITH REDUCED GENE EXPRESSION TO MITIGATE IMMUNE CELL RECOGNITION | ALDARONDO, DASIA ALI | 53d |
| 17010707 | METHODS OF PREPARING T CELLS FOR T CELL THERAPY | MIANO, JOSEPH PAUL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16695894 | CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND METHODS OF USE THEREOF | HALVORSON, MARK | 71d overdue |
| 17064241 | Plastic Jacket for Vial Labeling Systems | WENG, KAI H | 15d |
| 17841041 | SELECTIVE TARGETING OF HOST CD70+ ALLOREACTIVE CELLS TO PROLONG ALLOGENEIC CAR T CELL PERSISTENCE | ZHU, JIANJIAN | 76d |
| 19353269 | SELECTIVE TARGETING OF HOST CD70+ ALLOREACTIVE CELLS TO PROLONG ALLOGENEIC CAR T CELL PERSISTENCE | ZHU, JIANJIAN | — |
| 18365014 | CHIMERIC CYTOKINE RECEPTORS BEARING A PD-1 ECTODOMAIN | SANG, HONG | — |
| 17010707 | METHODS OF PREPARING T CELLS FOR T CELL THERAPY | MIANO, JOSEPH PAUL | — |
| Art Unit | Apps |
|---|---|
| 1631 | 3 |
| 1646 | 2 |
| 1647 | 1 |
| 3781 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19353269 | SELECTIVE TARGETING OF HOST CD70+ ALLOREACTIVE CELLS TO PROLONG ALLOGENEIC CAR T CELL PERSISTENCE | ZHU, JIANJIAN | 1631 | §103§112DP | Non-Final OA | — | Pending | Oct 08, 2025 |
| 18365014 | CHIMERIC CYTOKINE RECEPTORS BEARING A PD-1 ECTODOMAIN | SANG, HONG | 1646 | §102§103DP | Final Rejection | — | Pending | Aug 03, 2023 |
| 18361056 | ENGINEERED CELLS WITH REDUCED GENE EXPRESSION TO MITIGATE IMMUNE CELL RECOGNITION | ALDARONDO, DASIA ALI | 1647 | §103 | Non-Final OA | 53d | Pending | Jul 28, 2023 |
| 17841041 | SELECTIVE TARGETING OF HOST CD70+ ALLOREACTIVE CELLS TO PROLONG ALLOGENEIC CAR T CELL PERSISTENCE | ZHU, JIANJIAN | 1631 | §103§112DPOther | Final Rejection | 76d | Pending | Jun 15, 2022 |
| 17064241 | Plastic Jacket for Vial Labeling Systems | WENG, KAI H | 3781 | §103 | Final Rejection | 15d | Pending | Oct 06, 2020 |
| 17010707 | METHODS OF PREPARING T CELLS FOR T CELL THERAPY | MIANO, JOSEPH PAUL | 1631 | §101§103§112 | Non-Final OA | — | Pending | Sep 02, 2020 |
| 16695894 | CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND METHODS OF USE THEREOF | HALVORSON, MARK | 1646 | §103§112 | Non-Final OA | 71d overdue | Pending | Nov 26, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial